Reporting of Human Adenoviruses Has Declined Since COVID-19
FRIDAY, Dec. 27, 2024 -- Reporting of human adenovirus (HAdV) types decreased since the COVID-19 pandemic, according to research published in the Dec. 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Fatima Abdirizak, M.P.H., from the CDC in Atlanta, and colleagues summarized the distribution of HAdV types reported to the National Adenovirus Type Reporting System during 2017 to 2023.
The researchers found that 2,241 HAdV specimens with typing results were reported during the seven-year period. During 2017 to 2019, the number of specimens with HAdV typing results reported varied annually (range, 389 to 562) and decreased during 2020 to 2023 (range, 58 to 356). Six HAdV types (1 to 4, 7, and 14) accounted for 88.3 percent of typed specimens reported during 2017 to 2023; overall, 17.0 percent of specimens were outbreak-related. During 2021 to 2022, an increase in type 41 reporting was associated with a hepatitis cluster. Since the COVID-19 pandemic, there was a decrease seen in reporting to the National Adenovirus Type Reporting System, despite continued HAdV circulation reported through passive laboratory surveillance.
"Expanded laboratory capacity to type HAdVs and enhanced reporting could improve national understanding of HAdV circulation patterns and better guide public health prevention strategies," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Further Support and Information on COVID-19
Read this next
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
Prevention Strategies Developed for Cardiovascular Manifestations of COVID
FRIDAY, Sept. 26, 2025 -- Prevention strategies for cardiovascular manifestations of acute and long COVID are discussed in a report published online Sept. 18 in the European...
Inpatient Hep C Consultation After Delivery Tied to Better Treatment Completion
TUESDAY, Sept. 23, 2025 -- Providing immediate bedside hepatitis C virus (HCV) consultation at discharge from labor and delivery for women with HCV-affected pregnancies is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.